1-3 of 3
Lucien Gazi
Close
Sort by
Journal Articles

Clinical Pharmacology of CTL019 in Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)

Rakesh Awasthi, PhD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Ulrich Jaeger, MD, Samantha Jaglowski, MD MPH, Stephen Ronan Foley, MD FRCPC, Koen Van Besien, MD PhD, Nina D. Wagner-Johnston, MD, Marie Jose Kersten, MD PhD, Stephen J. Schuster, MD, Gilles Andre Salles, MD PhD, Richard Thomas Maziarz, MD, Oezlem Anak, MD, Lida Bubuteishvili Pacaud, MD, Lucien Gazi, PhD, Edward Waldron, PhD, Jason Hamilton, PhD, Iulian Pruteanu, PhD, Feng Tai, PhD, Karen Thudium Mueller, PharmD,MSc, Edmund K. Waller, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5211.
https://doi.org/10.1182/blood.V130.Suppl_1.5211.5211
Published: 2017
Journal Articles

Panobinostat Plus Azacitidine in Adult Patients with MDS, CMML, or AML: Results of a Phase 2b Study

Guillermo Garcia-Manero, MD, Mikkael A. Sekeres, MD MS, Miklos Egyed, MDPhD Prof., Giuliana Alimena, MD, Carlos Graux, Jamie D. Cavenagh, MD, Huda Salman, Arpad Illes, MD PhD, Pierre Fenaux, MD PhD, Daniel J. DeAngelo, Reinhard Stauder, MD MSc, Karen Yee, MD, Nancy Y Zhu, MDFRCPC, Je-Hwan Lee, MD PhD, David Valcarcel, MD PhD, Alan MacWhannell, Zita Borbenyi, MD PhD, Antje Wegener, Lucien Gazi, Suddhasatta Acharyya, PhD, Florence Binlich, Oliver G. Ottmann, MD
Journal: Blood
Blood (2015) 126 (23): 2861.
https://doi.org/10.1182/blood.V126.23.2861.2861
Published: 2015
Journal Articles

Effects of Hepatic Function on the Pharmacokinetics and Safety of Panobinostat in Patients with Advanced Cancer: A Phase I Study

Dagmar Hess, MD, Nicole Hagner, MD, Sally Clive, MD, Hans Gelderblom, MD, PhD, Eva Rossmann, MD, PhD, Neeraj Agarwal, MD, Maria Grazia Porro, PhD, Thomas Hengelage, PhD, Annie St-Pierre, PhD, Lucien Gazi, PhD, Jason Li, PhD, Margaret M. Woo, PharmD, Sunil Sharma, MD
Journal: Blood
Blood (2011) 118 (21): 5007.
https://doi.org/10.1182/blood.V118.21.5007.5007
Published: 2011